Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 275-702-5 | CAS number: 71617-10-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Toxicity to reproduction: other studies
Administrative data
- Endpoint:
- toxicity to reproduction: other studies
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- During 2001-11-05 and 2002-03-19
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- Except for the following deviations, this study was conducted in compliance with the OECD Principles of Good Laboratory Practice as revised in 1997 (ENV/MC/CHEM (98) 17) and with the German Principles of Good Laboratory Practice (Bundesgesetzblatt Part I, No. 21 of May 14, 2001). The deviations were as folIows: The expiry date (stability) of the test article was provided by the sponsor after completion of the study. Homogeneity and stability of the test substance in the formulation for administration were not determined. Homogeneity was ensured by mixing and checked visualIy. The test substance characteristics were not suggestive of rapid reaction with the formulation agents.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: This study was conducted in accordance with: OECD, Protocol of the conduct of the rodent uterotrophic assay, Draft protocol B - Immature female rats with sub-cutaneous administration (April 20, 2000).
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes
- Type of method:
- in vivo
Test material
- Reference substance name:
- Isopentyl p-methoxycinnamate
- EC Number:
- 275-702-5
- EC Name:
- Isopentyl p-methoxycinnamate
- Cas Number:
- 71617-10-2
- Molecular formula:
- C15H20O3
- IUPAC Name:
- isopentyl p-methoxycinnamate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Experimental animals
The study was conducted in juvenile female rats - animals recommended in the OECD protocol for these validation studies. At the start of the study, the animals were 19 days old and had starting weights of 29 - 36 g.
SPF-bred Wistar rats of the strain HsdCpb:WU from the Harlan Winkelmann GmbH Experimental Animal Breeders in Borchen, District of Paderborn were used.
Housing conditions
During the adaptation period, the animals were conventionally kept in polycarbonate cages type III (one foster dam with six or seven juvenile animals per cage). The cages ware not changed during the adaptation period.
During the test period, the animals were conventionally kept in polycarbonate cages type III (three animals per cage). Low-dust wood shavings type BK 8/15 (Supplier: Ssniff, Spezialdiäten GmbH, Soest/ Westphalia) were used as litter. The wood shavings were spot-checked tor contaminants levels and the records are filed at Bayer AG. The analytical results afforded no evidence for an effect on the study objective.
Cages and bedding material were not changed during the test period.
The cages containing the experimental animals ware placed on racks, separated by groups, in ascending animal number order. All animals taking part in this study were kept in the same animal room.
Environmental conditions
The environmental conditions in the animal room were standardized as follows:
room temperature: 22 ± 2°C
relative humidity: approx. 55 ± 5%
ligh/dark cycle: 12-hour artificial lighting
air exchange rate: approx. 10 times per hour
Occasional deviations from these conditions occurred, e.g. due to cleaning the animal room. They had no perceptible effect on the study routine.
Administration / exposure
- Route of administration:
- subcutaneous
- Vehicle:
- corn oil
- Details on exposure:
- Groups of 6 juvenile female rats of the strain HsdCpb:WU were administered isopentyl p-methoxycinnamate once a day at levels of 0 (untreated), 0 (vehicle control) 200 and 1000 mg/kg body weight subcutaneously for a period of three days. In two aditional groups of 6 juvenile female rats each the females were treated once a day fo 3 consecutive days with 0.3 and 1.0 µg/kg 17α-ethinylestradiol (positive control). The vehicle used for all groups except untreated control was corn oil.
- Analytical verification of doses or concentrations:
- no
- Details on analytical verification of doses or concentrations:
- no data available
- Duration of treatment / exposure:
- 3 days
- Frequency of treatment:
- once a day
- Duration of test:
- 3 days
Doses / concentrations
- Remarks:
- Doses / Concentrations:
Dose levels of 200 and 1000 mg/kg Neo Heliopan E1000 were included in this study.
Basis:
no data
- No. of animals per sex per dose:
- 6 female rats per dose group
- Control animals:
- yes, concurrent no treatment
- yes, concurrent vehicle
- Details on study design:
- The study methodology conformed to the OECD Validation work on in-vivo uterotrophic screening assay, OECD protocol of the conduct of the rodent uterotrophic assay, Draft protocol B - Immature female rats with sub-cutaneous administration (April 20, 2000).
Groups of 6 juvenile female rats were administered the test substance once a day at levels of 200 and 1000 mg/kg body weight subcutaneously for a period of three days. 17α-ethinylestradiol in doses of 0.3 and 1.0 μg/kg body weight served as positive control. For the negative control one animal group received the vehicle (corn oil) and one animal group remained untreated. At termination of the study the animals were necropsied and the organ weights of the uteri (wet and blotted) were determined. - Statistics:
- The results of the animal observations, organ, body and feed weights were collected and processed on-line and off-line.
The quantitative results for individual animals were used to calculate arithmetic group means and standard deviations. The results for the groups that received the test substance were compared with those for the vehicle contral group. The vehicle contral group was additionally compared to the untreated control group. Significant differences were indicated by '+' for p=< 0.05 and '++' for p=< 0.01.
The statistical evaluation of data related to body and organ weights as well as feed intake is performed using SAS routines.
Statistical evaluation on body weight and organ weight data were done using the Dunnet test in connection with a variance analysis. Relative organ w eights are submitted to a logarithmic transformation prior to the statistical analysis.
In case of numbers of values too low to calculate test statistics this is indicated by '0' or '-' in the tables shown in the results section and by 'ne' (not calculated) or '0' in the tables of the Annex. The individual results listed in the Annex to this report have been rounded off. Calculation of means and variances was based in part on the non-rounded original values. Some of the values in the tables of individual body weights may be missing. This may be the consequence of a technical defect which occured during on-line data collection or of a value which can not be listed (because of an error in weighing and a failure to meet printer format) or is unrealistic on account of a weighing error and deleted.
Results and discussion
Effect levels
- Dose descriptor:
- dose level:
- Effect level:
- > 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- other: Endpoint: Increase in uterine weight
Observed effects
No treatment related mortality was observed.
No toxicologically significant effect on the feed intake was observed.
Body weights were not affected by treatment.
At necropsy, a dose-dependent enlargement of uteri and an increased uterine wet and bIotted weight were observed for the positive control group at 0.3 and 1.0 µg/kg 17α-ethinylestradioI. No effects on uterine weights were observed at 200 and 1000 mg/kg isopentyl p-methoxycinnamate.
Any other information on results incl. tables
not applicable
Applicant's summary and conclusion
- Conclusions:
- In conclusion, no estrogenic effects were detected in the uterotrophic assay on juvenile female rats at sub-cutaneous doses of 1000 mg isopentyl p-methoxycinnamate per kg bw and below.
- Executive summary:
The dose-response of the test substance isopentyl p-methoxycinnamate following repeated subcutaneously administration was examined in an in-vivo uterotrophic screening assay (three-day treatment) using juvenile female Wistar rats.The study methodology conformed to the OECD Validation work on in-vivo uterotrophic screening assay, OECD, Protocol of the conduct of the rodent uterotrophic assay, Draft protocol B-Immature female rats with sub-cutaneous administration (April 20, 2000). Groups of 6 juvenile female rats of the strain HsdCpb:WU were administered isopentyl p-methoxycinnamate once a day at levels of 0 (untreated), 0 (vehicle control) 20 and 1000 mg/kg bwfor a period of three days. In two additional groups of 6 juvenile female rats, each of the females were treated once a day for 3 consecutive days with either 0.3 and 1.0 µg/kg 17alpha-ethinylestradiol (positive control). The vehicle used for all groups except untreated control was corn oil. Clinical observations were performed daily. Body weights ware determined daily. Feed intake was determined per group at termination (day 3). Gross necropsy (with uterus weights and tissue sampling) was performed on all animals at termination.
Regarding state of health or general behaviour of the animals, mortality, body weights, and feed intake, there was no difference between the untreated animals and animals treated with isopentyl p-methoxycinnamate.
No effects on uterine weight were observed at 200 and 1,000 mg/kg isopentyl p-methoxycinnamate. An enlargement of uterus was observed and increased uterine weights were determined at 0.3 and 1.0 µg/kg ethinylestradiol (positive control). In conclusion, no estrogenic effects were detected in the uterotrophic assay on juvenile female rats at sub-cutaneous doses of 1000 mg isopentyl p-methoxycinnamate per kg body weight and below.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)